Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The price of Pacific Biosciences of California Inc (NASDAQ: PACB) closed at $1.33 in the last session, down -3.62% from day before closing price of $1.38. In other words, the price has decreased by -$3.62 from its previous closing price. On the day, 7.36 million shares were traded. PACB stock price reached its highest trading level at $1.4199 during the session, while it also had its lowest trading level at $1.3.
Ratios:
We take a closer look at PACB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.87 and its Current Ratio is at 6.68. In the meantime, Its Debt-to-Equity ratio is 7.63 whereas as Long-Term Debt/Eq ratio is at 7.60.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 19 ’25 when Farmer Michele sold 5,195 shares for $1.00 per share. The transaction valued at 5,200 led to the insider holds 269,259 shares of the business.
HENRY CHRISTIAN O sold 12,497 shares of PACB for $17,583 on Mar 03 ’25. The insider now owns 2,225,357 shares after completing the transaction at $1.41 per share. On Mar 03 ’25, another insider, Van Oene Mark, who serves as the insider of the company, sold 6,486 shares for $1.41 each. As a result, the insider received 9,126 and left with 1,497,695 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PACB now has a Market Capitalization of 399113056 and an Enterprise Value of 758113600. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.62 while its Price-to-Book (P/B) ratio in mrq is 4.35. Its current Enterprise Value per Revenue stands at 4.976 whereas that against EBITDA is -3.169.
Stock Price History:
The Beta on a monthly basis for PACB is 2.17, which has changed by -0.14193547 over the last 52 weeks, in comparison to a change of 0.20277917 over the same period for the S&P500. Over the past 52 weeks, PACB has reached a high of $2.72, while it has fallen to a 52-week low of $0.85. The 50-Day Moving Average of the stock is 2.58%, while the 200-Day Moving Average is calculated to be -13.51%.
Shares Statistics:
According to the various share statistics, PACB traded on average about 9.21M shares per day over the past 3-months and 8293140 shares per day over the past 10 days. A total of 300.04M shares are outstanding, with a floating share count of 264.16M. Insiders hold about 11.97% of the company’s shares, while institutions hold 65.86% stake in the company. Shares short for PACB as of 1752537600 were 44383358 with a Short Ratio of 4.82, compared to 1749772800 on 39640882. Therefore, it implies a Short% of Shares Outstanding of 44383358 and a Short% of Float of 16.830000000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
